Identification of cellular genes induced in human cells after activation of the OAS/RNaseL pathway by Vaccinia Virus recombinants expressing these antiviral enzymes

Journal of Interferon and Cytokine Research

Volumn 30, Issue 3, 2010, Pages 171-188

  Domingo Gil, Elena ^b   González, José Manuel ^a   Esteban, Mariano ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ANTIVIRUS AGENT; INTERFERON; RIBONUCLEASE L;

ANIMAL CELL; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL GROWTH; CONTROLLED STUDY; COX5A GENE; ESR2 GENE; GADD45B GENE; GENE; GENE IDENTIFICATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; IFI6 GENE; KCTD11 GENE; MICROARRAY ANALYSIS; MIPEP GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PDCD6 GENE; PLA2G2A GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RUNX2 GENE; TNFAIP8L2 GENE; TRANSLATION REGULATION; UNINDEXED SEQUENCE; VACCINIA VIRUS; VIRUS RECOMBINANT;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; ENDORIBONUCLEASES; HELA CELLS; HUMANS; MICROARRAY ANALYSIS; MITOCHONDRIA; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UP-REGULATION; VACCINIA VIRUS; VIRAL PROTEINS;

VACCINIA VIRUS;

EID: 77949922045     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0037     Document Type: Article

References (73)

1. Ajuh P, Sleeman J, Chusainow J, Lamond AI. 2001. A direct interaction between the carboxyl-terminal region of CDC5L and the WD40 domain of PLRG1 is essential for pre-mRNA splicing. J Biol Chem 276(45):42370-42381
2. Bartsch DK, Fendrich V, Slater EP, Sina-Frey M, Rieder H, Greenhalf W, Chaloupka B, Hahn SA, Neoptolemos JP, Kress R. 2005. RNASEL germline variants are associated with pancreatic cancer. Int J Cancer 117(5):718-722
3. Belinsky GS, Rajan TV, Saria EA, Giardina C, Rosenberg DW. 2007. Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth. Mol Carcinog 46(2):106-116
4. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 57:289-300
5. Bisbal C, Silverman RH. 2007. Diverse functions of RNase L and implications in pathology. Biochimie 89(6-7):789-798
6. Blyth K, Vaillant F, Hanlon L, Mackay N, Bell M, Jenkins A, Neil JC, Cameron ER. 2006. Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo. Cancer Res 66(4):2195-2201
7. Brown T, Mackey K, Du T. 2004. Analysis of RNA by northern and slot blot hybridization. Curr Protoc Mol Biol. Sep;Chapter 4:Unit 4.9
8. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS. 2002. RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 32(4):581-583
9. Castelli J, Wood KA, Youle RJ. 1998. The 2-5A system in viral infection and apoptosis. Biomed Pharmacother 52(9):386-390
10. Chew A, Buck EA, Peretz S, Sirugo G, Rinaldo P, Isaya G. 1997. Cloning, expression, and chromosomal assignment of the human mitochondrial intermediate peptidase gene (MIPEP). Genomics 40(3):493-496
11. Crawford DR, Lauzon RJ, Wang Y, Mazurkiewicz JE, Schools GP, Davies KJ. 1997. 16S mitochondrial ribosomal RNA degradation is associated with apoptosis. Free Radic Biol Med 22(7):1295-1300
12. de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, Silverman RH, Williams BR. 2001. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 69(6):912-920
13. Der SD, Zhou A, Williams BR, Silverman RH. 1998. Identifi cation of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 95(26):15623-15628
14. Di Marcotullio L, Ferretti E, De Smaele E, Argenti B, Mincione C, Zazzeroni F, Gallo R, Masuelli L, Napolitano M, Maroder M, Modesti A, Giangaspero F, Screpanti I, Alesse E, Gulino A. 2004. REN(KCTD11) is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma. Proc Natl Acad Sci USA 101(29):10833-10838
15. Diaz-Guerra M, Rivas C, Esteban M. 1997a. Activation of the IFNinducible enzyme RNase L causes apoptosis of animal cells. Virology 236(2):354-363
16. Diaz-Guerra M, Rivas C, Esteban M. 1997b. Inducible expression of the 2-5A synthetase/RNase L system results in inhibition of vaccinia virus replication. Virology 227(1):220-228
17. Domingo-Gil E, Esteban M. 2006. Role of mitochondria in apoptosis induced by the 2-5A system and mechanisms involved. Apoptosis 11(5):725-738
18. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, Ganem D, Derisi JL, Chow SA, Silverman RH. 2007. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci USA 104(5):1655-1660
19. Dong B, Silverman RH. 1995. 2-5A-dependent RNase molecules dimerize during activation by 2-5A. J Biol Chem 270(8):4133-4137
20. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R. 2007. A systems biology approach for pathway level analysis. Genome Res 17(10):1537-1545
21. Flodstrom-Tullberg M, Hultcrantz M, Stotland A, Maday A, Tsai D, Fine C, Williams B, Silverman R, Sarvetnick N. 2005. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J Immunol 174(3):1171-1177
22. Geiss G, Jin G, Guo J, Bumgarner R, Katze MG, Sen GC. 2001. A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling. J Biol Chem 276(32):30178-30182
23. Ghosh A, Sarkar SN, Sen GC. 2000. Cell growth regulatory and antiviral effects of the P69 isozyme of 2-5 (A) synthetase. Virology 266(2):319-328
24. Gil J, Esteban M. 2004. Vaccinia virus recombinants as a model system to analyze interferon-induced pathways. J Interferon Cytokine Res 24(11):637-646
25. Gil J, Garcia MA, Gomez-Puertas P, Guerra S, Rullas J, Nakano H, Alcami J, Esteban M. 2004. TRAF family proteins link PKR with NF-kappa B activation. Mol Cell Biol 24(10):4502-4512
26. Guerra S, Najera JL, Gonzalez JM, Lopez-Fernandez LA, Climent N, Gatell JM, Gallart T, Esteban M. 2007. Distinct gene expression profi ling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC. J Virol 81(16):8707-8721
27. Holcik M, Sonenberg N. 2005. Translational control in stress and apoptosis. Nat Rev Mol Cell Biol 6(4):318-327
28. Huhtinen HT, Gronroos JO, Gronroos JM, Uksila J, Gelb MH, Nevalainen TJ, Laine VJ. 2006. Antibacterial effects of human group IIA and group XIIA phospholipase A2 against Helicobacter pylori in vitro. Apmis 114(2):127-130
29. Imamov O, Shim GJ, Warner M, Gustafsson JA. 2005. Estrogen receptor beta in health and disease. Biol Reprod 73(5):866-871
30. Isaacs A, Lindenmann J. 1957. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 147(927):258-267
31. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, Yamanishi Y. 2008. KEGG for linking genomes to life and the environment. Nucleic Acids Res 36(Database issue):D480-D484
32. Kerr IM, Cayley PJ, Silverman RH, Knight M. 1982. The antiviral action of interferon. Philos Trans R Soc Lond B Biol Sci 299(1094):59-67
33. Khatri P, Bhavsar P, Bawa G, Draghici S. 2004. Onto-Tools: an ensemble of web-accessible, ontology-based tools for the functional design and interpretation of high-throughput gene expression experiments. Nucleic Acids Res 32(Web Server issue):W449-W456
34. Khatri P, Sellamuthu S, Malhotra P, Amin K, Done A, Draghici S. 2005. Recent additions and improvements to the Onto-Tools. Nucleic Acids Res 33(Web Server issue):W762-W765
35. Kipreos ET, Lander LE, Wing JP, He WW, Hedgecock EM. 1996. cul-1 is required for cell cycle exit in C. elegans and identifi es a novel gene family. Cell 85(6):829-839
36. Kruger S, Silber AS, Engel C, Gorgens H, Mangold E, Pagenstecher C, Holinski-Feder E, von Knebel Doeberitz M, Moeslein G, Dietmaier W, Stemmler S, Friedl W, Ruschoff J, Schackert HK. 2005. Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary nonpolyposis colorectal cancer: a case-control study. Lancet Oncol 6(8):566-572
37. Le Roy F, Bisbal C, Silhol M, Martinand C, Lebleu B, Salehzada T. 2001. The 2-5A/RNase L/RNase L inhibitor (RLI) [correction of (RNI)] pathway regulates mitochondrial mRNAs stability in interferon alpha-treated H9 cells. J Biol Chem 276(51):48473-48482
38. Le Roy F, Salehzada T, Bisbal C, Dougherty JP, Peltz SW. 2005. A newly discovered function for RNase L in regulating translation termination. Nat Struct Mol Biol 12(6):505-512
39. Le Roy F, Silhol M, Salehzada T, Bisbal C. 2007. Regulation of mitochondrial mRNA stability by RNase L is translation-dependent and controls IFNalpha-induced apoptosis. Cell Death Differ 14(8):1406-1413
40. Li XL, Blackford JA, Judge CS, Liu M, Xiao W, Kalvakolanu DV, Hassel BA. 2000. RNase-L-dependent destabilization of interferon- induced mRNAs. A role for the 2-5A system in attenuation of the interferon response. J Biol Chem 275(12):8880-8888
41. Li XL, Ezelle HJ, Kang TJ, Zhang L, Shirey KA, Harro J, Hasday JD, Mohapatra SK, Crasta OR, Vogel SN, Cross AS, Hassel BA. 2008. An essential role for the antiviral endoribonuclease, RNase-L, in antibacterial immunity. Proc Natl Acad Sci USA 105(52):20816-20821
42. Li G, Xiang Y, Sabapathy K, Silverman RH. 2004. An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase. J Biol Chem 279(2):1123-1131
43. Liang SL, Quirk D, Zhou A. 2006. RNase L: its biological roles and regulation. IUBMB Life 58(9):508-514
44. Lim CS. 2007. Is SIRT6 a new biomarker for oxidative stress and longevity assurance gene? Med Hypotheses 69(1):231
45. Liu W, Liang SL, Liu H, Silverman R, Zhou A. 2007. Tumour suppressor function of RNase L in a mouse model. Eur J Cancer 43(1):202-209
46. Malathi K, Paranjape JM, Bulanova E, Shim M, Guenther-Johnson JM, Faber PW, Eling TE, Williams BR, Silverman RH. 2005. A transcriptional signaling pathway in the IFN system mediated by 2′-5′s-oligoadenylate activation of RNase L. Proc Natl Acad Sci USA 102(41):14533-14538
47. Marie I, Rebouillat D, Hovanessian AG. 1999. The expression of both domains of the 69/71 kDa 2′,5′ oligoadenylate synthetase generates a catalytically active enzyme and mediates an anti-viral response. Eur J Biochem 262(1):155-165
48. Oliveros JC. 2007. FIESTA@BioinfoGP. An interactive server for analyzing DNA microarray experiments with replicates. Available from: http://bioinfogp. cnb.csic.es/tools/FIESTA
49. Paez E, Esteban M. 1984. Resistance of vaccinia virus to interferon is related to an interference phenomenon between the virus and the interferon system. Virology 134(1):12-28
50. Rebouillat D, Hovanessian AG. 1999. The human 2′,5′- oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J Interferon Cytokine Res 19(4):295-308
51. Rice AP, Roberts WK, Kerr IM. 1984. 2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication. J Virol 50(1):220-228
52. Rodriguez JF, Smith GL. 1990. Inducible gene expression from vaccinia virus vectors. Virology 177(1):239-250
53. Ryman KD, White LJ, Johnston RE, Klimstra WB. 2002. Effects of PKR/RNase L-dependent and alternative antiviral pathways on alphavirus replication and pathogenesis. Viral Immunol 15(1):53-76
54. Sadler AJ, Williams BR. 2008. Interferon-inducible antiviral effectors. Nat Rev Immunol 8(7):559-568
55. Samuel CE. 2001. Antiviral actions of interferons. Clin Microbiol Rev 14(4):778-809, table of contents
56. Samuel MA, Whitby K, Keller BC, Marri A, Barchet W, Williams BR, Silverman RH, Gale M, Jr., Diamond MS. 2006. PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol 80(14):7009-7019
57. Schubert EL, Lee MK, Newman B, King MC. 1999. Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility. J Steroid Biochem Mol Biol 71(1-2): 21-27
58. Seet BT, Johnston JB, Brunetti CR, Barrett JW, Everett H, Cameron C, Sypula J, Nazarian SH, Lucas A, McFadden G. 2003. Poxviruses and immune evasion. Annu Rev Immunol 21:377-423
59. Silverman RH. 2003. Implications for RNase L in prostate cancer biology. Biochemistry 42(7):1805-1812
60. Silverman RH. 2007a. A scientifi c journey through the 2-5A/RNase L system. Cytokine Growth Factor Rev 18(5-6):381-388
61. Silverman RH. 2007b. Viral Encounters with OAS and RNase L during the IFN Antiviral Response. J Virol 81(23):12720-12729
62. Smyth GK. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3.
63. Soulat D, Burckstummer T, Westermayer S, Goncalves A, Bauch A, Stefanovic A, Hantschel O, Bennett KL, Decker T, Superti-Furga G. 2008. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J 27(15):2135-2146
64. Sun H, Gong S, Carmody RJ, Hilliard A, Li L, Sun J, Kong L, Xu L, Hilliard B, Hu S, Shen H, Yang X, Chen YH. 2008. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell 133(3):415-426
65. Wisniewski HG, Burgess WH, Oppenheim JD, Vilcek J. 1994. TSG-6, an arthritis-associated hyaluronan binding protein, forms a stable complex with the serum protein inter-alpha-inhibitor. Biochemistry 33(23):7423-7429
66. Wreschner DH, James TC, Silverman RH, Kerr IM. 1981. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2′p)nA) in interferon-treated cells. Nucleic Acids Res 9(7):1571-1581
67. Xiang Y, Wang Z, Murakami J, Plummer S, Klein EA, Carpten JD, Trent JM, Isaacs WB, Casey G, Silverman RH. 2003. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2′,5′-oligoadenylates. Cancer Res 63(20):6795-6801
68. Yang SH, Sarkar SN, Liu R, Perez EJ, Wang X, Wen Y, Yan LJ, Simpkins JW. 2009. Estrogen receptor beta as a mitochondrial vulnerability factor. J Biol Chem 284(14):9540-9548
69. Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, Fornace AJ, Jr., Liebermann DA, Bottinger EP, Roberts AB. 2003. Transforming growth factor-beta-induced apoptosis is mediated by Smaddependent expression of GADD45b through p38 activation. J Biol Chem 278(44):43001-43007
70. Zheng X, Silverman RH, Zhou A, Goto T, Kwon BS, Kaufman HE, Hill JM. 2001. Increased severity of HSV-1 keratitis and mortality in mice lacking the 2-5A-dependent RNase L gene. Invest Ophthalmol Vis Sci 42(1):120-126
71. Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B, Chang A, Trapp B, Fairchild R, Colmenares C, Silverman RH. 1997. Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate- dependent RNase L. EMBO J 16(21):6355-6363
72. Zhou A, Paranjape JM, Hassel BA, Nie H, Shah S, Galinski B, Silverman RH. 1998. Impact of RNase L overexpression on viral and cellular growth and death. J Interferon Cytokine Res 18(11):953-961
73. Zu YL, Maekawa T, Nomura N, Nakata T, Ishii S. 1993. Regulation of trans-activating capacity of CRE-BPa by phorbol ester tumor promoter TPA. Oncogene 8(10):2749-2758